tiprankstipranks
Trending News
More News >
NextCell Pharma AB (DE:65G)
FRANKFURT:65G
Germany Market
Advertisement

NextCell Pharma AB (65G) Income Statement

Compare
0 Followers

NextCell Pharma AB Income Statement

Last quarter (Q4 2025), NextCell Pharma AB's total revenue was kr2.60M, an increase of 58.26% from the same quarter last year. In Q4, NextCell Pharma AB's net income was kr-8.63M. See NextCell Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
kr 10.94Mkr ―kr 10.66Mkr 10.11Mkr 5.59M
Gross Profit
kr -35.87Mkr ―kr -4.56Mkr -884.83Kkr -22.26M
Operating Expenses
kr 0.00kr ―kr 38.61Mkr 40.12Mkr 12.76M
Depreciation and Amortization
kr 2.52Mkr ―kr 974.67Kkr 447.88Kkr 457.34K
EBITDA
kr -32.63Mkr ―kr -40.99Mkr -39.36Mkr -34.10M
Operating Income
kr -35.87Mkr ―kr -43.17Mkr -41.00Mkr -35.02M
Other Income/Expenses
kr 728.70Kkr ―kr 1.21Mkr 1.19Mkr 469.57K
Pretax Income
kr -35.14Mkr ―kr -41.96Mkr -39.81Mkr -34.55M
Net Income
kr -35.14Mkr ―kr -41.96Mkr -39.81Mkr -34.08M
Per Share Metrics
Basic EPS
kr -0.46kr ―kr -0.57kr -0.58kr -0.50
Diluted EPS
kr -0.46kr ―kr -0.57kr -0.58kr -0.50
Weighted Average Shares Outstanding
76.41M 73.09M 68.76M 68.76M
Weighted Average Shares Outstanding (Diluted)
76.41M 73.09M 68.76M 68.76M
Currency in SEK

NextCell Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis